Subvenciones y ayudas para entidades sociales

Community-Partnered Nursing Research Centers (P20 Clinical Trial Optional)

Estados Unidos · US

Quién puede pedirla Others (see text field entitled "Additional Information on Eligibility" for clarification) · Special district governments · Native American tribal organizations (other than Federally recognized tribal governments) · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Small businesses · City or township governments · Independent school districts · Private institutions of higher education · For profit organizations other than small businesses · Public and State controlled institutions of higher education · Public housing authorities/Indian housing authorities · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Native American tribal governments (Federally recognized) · State governments · County governments

The purpose of this initiative is to support the development of innovative research centers to foster nursing-led programs that promote community-partnered research to address persistent health challenges. Center applications developed in response to this RFA should propose strategies to strengthen the research infrastructure by establishing or expanding centralized research resources in School or College of Nursing (SON/CON), developing and enhancing nurse-led interdisciplinary teams, and building expertise in community-partnered research through conducting pilot research that applies NINR's research lenses. Center strategies should be informed by NINRs mission and should meaningfully engage the community throughout all activities.

Premio NIDCR para Científicos Dentistas con Doble Titulación: Vía a la Independencia (K99/R00 Ensayo Clínico No Permitido)

Estados Unidos · US

Quién puede pedirla Special district governments · Native American tribal governments (Federally recognized) · Small businesses · County governments · Independent school districts · For profit organizations other than small businesses · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Private institutions of higher education · State governments · City or township governments · Public and State controlled institutions of higher education · Native American tribal organizations (other than Federally recognized tribal governments) · Public housing authorities/Indian housing authorities · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Others (see text field entitled "Additional Information on Eligibility" for clarification)

El propósito del programa NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00) es desarrollar y mantener una sólida cohorte de científicos dentistas financiados de forma independiente dedicados a mejorar la salud dental, oral y craneofacial. Este programa está diseñado para facilitar una transición oportuna de científicos dentistas con doble titulación sobresalientes de puestos de investigación posdoctorales con mentor a puestos de facultad independientes, con permanencia o equivalentes, brindando apoyo durante dos años de capacitación con mentor y de tres a cinco años de investigación independiente. Una opción de cinco años de apoyo independiente (R00) está disponible para acomodar la capacitación clínica en un programa de especialidad dental con no más de 3 meses-persona de esfuerzo (25% de esfuerzo profesional a tiempo completo) en cualquier año de la fase R00.

Beca individual Ruth L. Kirschstein del Servicio Nacional de Investigación (NRSA) para estudiantes en instituciones sin programas de capacitación predoctorales institucionales de doble titulación financiados por los NIH (F30 para padres)

Estados Unidos · US

Quién puede pedirla Others (see text field entitled "Additional Information on Eligibility" for clarification) · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Public and State controlled institutions of higher education · Private institutions of higher education · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Small businesses · For profit organizations other than small businesses

Este Aviso de Oportunidad de Financiación (NOFO) apoyará a estudiantes en instituciones sin programas de capacitación predoctorales institucionales de doble titulación financiados por los NIH. El propósito de la beca predoctoral (F30) de doble doctorado Kirschstein-NRSA es mejorar la capacitación integrada en investigación y clínica de estudiantes predoctorales prometedores, que están matriculados en un programa de capacitación de doble doctorado combinado MD/PhD u otro (por ejemplo, DO/PhD, DDS/PhD, AuD/PhD, DVM/PhD), y que tienen la intención de seguir carreras como médicos/científicos clínicos. Los candidatos deben proponer un plan de capacitación clínica y de investigación integrado y un proyecto de investigación de tesis en campos científicos relacionados con la salud relevantes para las misiones de los Institutos y Centros participantes de los NIH. Se espera que la experiencia de la beca mejore claramente el potencial del individuo para desarrollarse como un médico/científico clínico productivo e independiente. Este NOFO está diseñado específicamente para candidatos que proponen investigaciones que no implican liderar un ensayo clínico independiente, un estudio de viabilidad de ensayo clínico o un ensayo clínico auxiliar, pero permite a los candidatos proponer experiencia de investigación en un ensayo clínico dirigido por un patrocinador o copatrocinador.

Beca Individual Ruth L. Kirschstein del Servicio Nacional de Investigación (NRSA) para Estudiantes en Instituciones con Programas de Capacitación Predoctoral de Doble Titulación Institucional Financiados por los NIH (F30 Principal)

Estados Unidos · US

Quién puede pedirla Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · For profit organizations other than small businesses · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Public and State controlled institutions of higher education · Private institutions of higher education · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Small businesses

Este Aviso de Oportunidad de Financiamiento (NOFO) apoyará a estudiantes en instituciones con programas de capacitación predoctoral de doble titulación institucional financiados por los NIH. El propósito de la beca predoctoral de doble doctorado Kirschstein-NRSA (F30) es mejorar la capacitación clínica y de investigación integrada de estudiantes predoctorales prometedores, que están matriculados en un programa combinado de MD/PhD u otro programa de capacitación de doble doctorado (por ejemplo, DO/PhD, DDS/PhD, AuD/PhD, DVM/PhD), y que tienen la intención de seguir carreras como médicos/científicos clínicos. Los candidatos deben proponer un plan de capacitación clínica y de investigación integrado y un proyecto de investigación de tesis en campos científicos relacionados con la salud relevantes para las misiones de los Institutos y Centros de los NIH participantes. Se espera que la experiencia de la beca mejore claramente el potencial del individuo para desarrollarse como un médico/científico clínico productivo e independiente. Este Aviso de Oportunidad de Financiamiento (NOFO) está diseñado específicamente para candidatos que proponen investigación que no implica liderar un ensayo clínico independiente, un estudio de viabilidad de ensayo clínico o un ensayo clínico auxiliar, pero permite a los candidatos proponer experiencia de investigación en un ensayo clínico dirigido por un patrocinador o copatrocinador.

Beca individual predoctoral Ruth L. Kirschstein del Servicio Nacional de Investigación (NRSA) (Padre F31)

Estados Unidos · US

Quién puede pedirla Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Private institutions of higher education · Public and State controlled institutions of higher education · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Small businesses · Others (see text field entitled "Additional Information on Eligibility" for clarification) · For profit organizations other than small businesses

El propósito de la beca individual predoctoral Ruth L. Kirschstein del Servicio Nacional de Investigación (NRSA) (Padre F31) es permitir que estudiantes predoctorales prometedores obtengan capacitación en investigación individualizada y con mentores de patrocinadores de facultad destacados mientras realizan proyectos de investigación de disertación en campos científicos relacionados con la salud relevantes para las misiones de los Institutos y Centros participantes de los NIH. La capacitación en investigación con mentores propuesta debe reflejar el proyecto de investigación de disertación del candidato y se espera que mejore claramente el potencial del individuo para convertirse en un científico investigador productivo e independiente. Esta Notificación de Oportunidad de Financiamiento (NOFO) no permite que los candidatos propongan liderar un ensayo clínico independiente, pero sí permite que los candidatos propongan experiencia en investigación en un ensayo clínico dirigido por un patrocinador o copatrocinador.

Beca individual sénior Ruth L. Kirschstein del Servicio Nacional de Investigación (NRSA) (F33 para padres)

Estados Unidos · US

Quién puede pedirla Public and State controlled institutions of higher education · Others (see text field entitled "Additional Information on Eligibility" for clarification) · For profit organizations other than small businesses · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Private institutions of higher education · Small businesses

Los Institutos Nacionales de Salud (NIH) otorgan becas de capacitación en investigación individual sénior a científicos experimentados que desean realizar cambios importantes en la dirección de sus carreras de investigación o que desean ampliar sus antecedentes científicos adquiriendo nuevas capacidades de investigación como investigadores independientes en campos de investigación relevantes para las misiones de los Institutos y Centros participantes de los NIH.

Beca Individual Postdoctoral Ruth L. Kirschstein del Servicio Nacional de Investigación (NRSA) (F32 Principal)

Estados Unidos · US

Quién puede pedirla Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Small businesses · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Public and State controlled institutions of higher education · Private institutions of higher education · For profit organizations other than small businesses

El propósito de la Beca Individual Postdoctoral Ruth L. Kirschstein del Servicio Nacional de Investigación (NRSA) (F32 Principal) es apoyar la capacitación en investigación de candidatos postdoctorales altamente prometedores que tienen el potencial de convertirse en investigadores productivos e independientes en campos de investigación científica relacionados con la salud relevantes para las misiones de los Institutos y Centros de los NIH participantes. Se espera que las solicitudes incorporen una tutoría excepcional.

Beca de capacitación en investigación institucional a corto plazo Ruth L. Kirschstein del Servicio Nacional de Investigación (NRSA) (T35 para padres)

Estados Unidos · US

Quién puede pedirla Private institutions of higher education · City or township governments · Public housing authorities/Indian housing authorities · Small businesses · Public and State controlled institutions of higher education · Native American tribal organizations (other than Federally recognized tribal governments) · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Special district governments · State governments · County governments · Independent school districts · Native American tribal governments (Federally recognized) · For profit organizations other than small businesses · Others (see text field entitled "Additional Information on Eligibility" for clarification)

Los Institutos Nacionales de Salud (NIH) otorgarán becas de capacitación en investigación institucional a corto plazo Ruth L. Kirschstein del Servicio Nacional de Investigación (NRSA) (T35) a instituciones nacionales elegibles para desarrollar y/o mejorar las oportunidades de capacitación en investigación para estudiantes predoctorales interesados en carreras dentro de la fuerza laboral de investigación biomédica, conductual o clínica. Muchos Institutos y Centros (IC) de los NIH utilizan este programa NRSA exclusivamente para apoyar experiencias intensivas de capacitación en investigación a corto plazo para estudiantes de profesiones de la salud (estudiantes de medicina, estudiantes de veterinaria y/o estudiantes de otros programas de profesiones de la salud) durante el verano. Este programa también tiene como objetivo fomentar la capacitación de estudiantes de posgrado en ciencias físicas o cuantitativas para que persigan intereses en carreras de investigación mediante una exposición e implicación a corto plazo en las ciencias relacionadas con la salud. La capacitación debe tener la profundidad suficiente para permitir a los becarios, al finalizar el programa, tener una exposición exhaustiva a los principios que subyacen a la realización de la investigación biomédica.

Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)

Estados Unidos · US

Quién puede pedirla Special district governments · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Public and State controlled institutions of higher education · Native American tribal organizations (other than Federally recognized tribal governments) · Public housing authorities/Indian housing authorities · Private institutions of higher education · County governments · Native American tribal governments (Federally recognized) · For profit organizations other than small businesses · Independent school districts · City or township governments · Small businesses · Others (see text field entitled "Additional Information on Eligibility" for clarification) · State governments · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education

This Notice of Funding Opportunity (NOFO) invites applications that propose to use mouse models to conduct rigorous preclinical testing of drugs or drug combinations currently used for other conditions, as well as investigational drugs at various stages of clinical development, predicted to be efficacious in AD/ADRD. This initiative will also support preclinical testing of repurposable or investigational drug candidates in combination with non-pharmacologic interventions leading to robust translational outcomes. The central goal is to establish robust proof of concept that will enable rational drug repurposing and combination therapy development for the treatment and prevention of AD/ADRD.

NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)

Estados Unidos · US

Quién puede pedirla County governments · Native American tribal organizations (other than Federally recognized tribal governments) · Special district governments · Small businesses · State governments · Public housing authorities/Indian housing authorities · Private institutions of higher education · Independent school districts · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Native American tribal governments (Federally recognized) · For profit organizations other than small businesses · City or township governments · Public and State controlled institutions of higher education · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education

This Notice of Funding Opportunity (NOFO) invites applications to use NHLBI-funded TransOmics for Precision Medicine (TOPMed) program to generate a large volume of integrated genetic and multi-omics data to facilitate discovery of the molecular mechanisms of Heart, Lung, Blood, and Sleep (HLBS) disorders. No funding will be provided under this NOFO. The genomic data and related phenotypic data will be deposited in a public NIH-designated controlled-access database such as the database for Genotypes and Phenotypes (dbGaP) and NHLBIs BioData Catalyst (BDC). The overall goal is to move from simply cataloguing genetic associations to understanding how genetic factors contribute to HLBS diseases at the molecular and cellular levels. This transformation will help move TOPMed from genetic Map to Mechanism with potential applications of AI and ML tool sets where possible, enabling functional genomics research that will accelerate mechanistic personalized medicine

Animal and Veterinary Innovation Centers (U18)

Estados Unidos · US

Quién puede pedirla Public and State controlled institutions of higher education · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Private institutions of higher education

The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for inclusion as Animal and Veterinary Innovation Centers, which are intended to form long-term partnerships to address priority areas for FDA's Center for Veterinary Medicine (CVM). This includes CVM developing cooperative agreement(s) with academic research institutions (public and private) to: 1. Drive research that supports the development of interventions to prevent, control, or eliminate Highly Pathogenic Avian Influenza (HPAI) virus in animals, or interventions that reduce the circulation of the virus in the ecosystem. Work may also include other emerging zoonotic disease threats or One Health issues in future years. 2. Drive research that supports the development of intentional genomic alternations in animals and the advancement of regulatory science in this field, with a focus on intentional genomic alternations that support agricultural resilience, food security, animal health, or public health. 3. Drive research that supports the development of products for minor species, minor uses in major species (dogs, cats, horses, cattle, pigs, chickens, and turkeys) and other unmet veterinary medical needs in major species that create a significant animal or public health burden.

Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)

Estados Unidos · US

Quién puede pedirla Others (see text field entitled "Additional Information on Eligibility" for clarification)

The purpose of this Notice of Funding Opportunity (NOFO) is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare diseases or conditions. Additionally, through the funding of collaborative, efficient, and/or innovative clinical trials, FDA expects to increase the number of approved treatments for rare diseases and exert a broad and positive impact on rare disease drug development.

Maximizing Investigators' Research Award (MIRA) (R35 - Clinical Trial Optional)

Estados Unidos · US

Quién puede pedirla Others (see text field entitled "Additional Information on Eligibility" for clarification) · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Independent school districts · Public housing authorities/Indian housing authorities · State governments · Special district governments · City or township governments · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Private institutions of higher education · Native American tribal organizations (other than Federally recognized tribal governments) · Small businesses · Public and State controlled institutions of higher education · Native American tribal governments (Federally recognized) · For profit organizations other than small businesses · County governments

The Maximizing Investigators' Research Award (MIRA) provides support for individual investigators for research within the scientific mission of NIGMS via a single grant to achieve the following:Increase the stability of funding for NIGMS-supported investigators, which could enhance their ability to take on ambitious scientific projects and approach problems more creatively;Increase flexibility for investigators to follow important new research directions within the NIGMS mission as opportunities arise, rather than being bound to specific aims proposed in advance of the studies;More widely distribute funding among the nation's highly talented and promising investigators to increase overall scientific productivity and the chances for important breakthroughs;Reduce the time spent by researchers writing and reviewing grant applications, allowing them to spend more time conducting research;Reduce the administrative burden associated with a PD/PI managing multiple NIGMS research grants; andEnable PD(s)/PI(s) to devote more time and energy to mentoring junior scientists in a more stable research environment.This NOFO invites applications from eligible NIGMS-funded investigators and from New Investigators proposing research that is aligned with NIGMS' scientific mission. The NOFO also allows renewal applications from all current MIRA grantees (including those previously funded as Early-Stage Investigators). Current Early-Stage Investigators (ESIs) should apply through the ESI MIRA NOFO, not this NOFO.

Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed)

Estados Unidos · US

Quién puede pedirla Independent school districts · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Public housing authorities/Indian housing authorities · Native American tribal governments (Federally recognized) · State governments · Special district governments · City or township governments · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Small businesses · County governments · Private institutions of higher education · Public and State controlled institutions of higher education · Native American tribal organizations (other than Federally recognized tribal governments) · For profit organizations other than small businesses

Responding to the needs of the scientific community to bolster a vibrant and sustainable research workforce, the Division of Kidney, Urologic, and Hematologic Diseases (KUH) at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has incorporated additional flexibilities for institutional training programs serving the mission interests of non-malignant kidney, urologic, and hematologic diseases, encompassing both adult and pediatric conditions. The purpose of this notice of funding opportunity is to invite applications for Institutional Network Awards (U2C-TL1) to recruit, train, and retain the next generation of researchers and provide them with the coordinated support, resources, and networks they need to succeed and lead. To maximize integration and promote a highly connected trainee community, institutions are invited to submit a single, unified U2C-TL1 application. Representation across all kidney, urologic, and hematologic disciplines is not expected or required. If feasible, applications may include multiple departments within and across institutions. It is expected that each U2C-TL1 award will actively participate in the Kidney, Urology and Hematology Research-Training Network (KUHR-TN), a nationwide coalition of individual U2C-TL1 awards.

Mind and Body Interventions to Restore Whole Person Health via Emotional Well-Being Mechanisms (R61/R33 Clinical Trial Required)

Estados Unidos · US

Quién puede pedirla State governments · Independent school districts · Native American tribal governments (Federally recognized) · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · County governments · Private institutions of higher education · Public and State controlled institutions of higher education · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · City or township governments · Native American tribal organizations (other than Federally recognized tribal governments) · Small businesses · Special district governments · Public housing authorities/Indian housing authorities · For profit organizations other than small businesses · Others (see text field entitled "Additional Information on Eligibility" for clarification)

The National Center for Complementary and Integrative Health (NCCIH) announces this Notice of Funding Opportunity (NOFO) to solicit applications for research on how mind and body interventions through psychological and/or physical inputs (e.g., mindfulness meditation, yoga, acupuncture, massage, and other brain and/or body based interventions) impact mechanisms of emotional well-being (EWB) and their associations with whole person health (WPH), consistent with the NIH priority to address the health needs of the American people and improve their well-being. The NOFO will support rigorous and well-powered mechanistic research studies that are supported by strong preliminary data. The studies should examine the effects of mind and body interventions on innovative mechanisms of EWB (as the primary outcome), as well as the associated relationship with the Whole Person Health Index (WPHI, as a secondary outcome). To enhance research safety, rigor, and efficiency of NIH-funded mechanistic clinical trials, this initiative will use a two-phased award funding mechanism (R61/R33). The funding will support an initial phase (R61) to establish feasibility benchmarks for the proposed mechanistic clinical trial(s), followed by a second phase (R33) to complete the full-scale trials, which will be contingent upon successful completion of R61 milestones. Applications should provide preliminary data that are comparable in quality and quantity to those expected for an R01 proposal.

INCLUDE Project: Clinical Trials Phased Awards for Down syndrome Research (R61/R33 Clinical Trial Required)

Estados Unidos · US

Quién puede pedirla Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Private institutions of higher education · Public housing authorities/Indian housing authorities · Others (see text field entitled "Additional Information on Eligibility" for clarification) · State governments · Native American tribal governments (Federally recognized) · City or township governments · Independent school districts · Public and State controlled institutions of higher education · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · For profit organizations other than small businesses · County governments · Small businesses · Special district governments · Native American tribal organizations (other than Federally recognized tribal governments)

The NIH INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Project seeks to improve health and quality-of-life for individuals with Down syndrome. The purpose of this Notice of Funding Opportunity (NOFO) encourages Exploratory/Developmental Phased Innovation (R61/R33) grant applications to support development of clinical trials to treat critical and co-occurring health conditions in individuals with Down syndrome. The proposed research aims should be milestone-driven. The total project period for an application submitted in response to this NOFO may not exceed five years. This NOFO provides support for up to two years (R61 phase) for preliminary/developmental/planning studies, followed by possible transition to clinical trial support (R33) of up to three years, although the total duration of the award may not exceed five years. This NOFO requires measurable R61 milestones.

INCLUDE Project: Transformative Research Awards for Down syndrome (R01 Clinical Trial Not Allowed)

Estados Unidos · US

Quién puede pedirla County governments · Special district governments · For profit organizations other than small businesses · Independent school districts · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · City or township governments · Private institutions of higher education · Native American tribal governments (Federally recognized) · Public housing authorities/Indian housing authorities · Small businesses · Native American tribal organizations (other than Federally recognized tribal governments) · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Others (see text field entitled "Additional Information on Eligibility" for clarification) · State governments · Public and State controlled institutions of higher education

The NIH INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Project seeks to improve health and quality-of-life for individuals with Down syndrome. The purpose of this Notice of Funding Opportunity (NOFO) is to solicit Transformative Research Award applications to support individual scientists or groups of scientists proposing groundbreaking, exceptionally innovative, original, and/or unconventional research that has the potential to create new scientific paradigms, establish entirely new and improved clinical approaches, or develop transformative technologies related to Down syndrome. Applications are welcome in all topics relevant to Down syndrome-related research or its co-occurring conditions. No preliminary data are required. Projects must clearly demonstrate, based on the strength of the logic, a compelling potential to produce a major impact in research related to Down syndrome.

INCLUDE Project: Exploratory/Developmental Research Awards for Down syndrome (R21 Clinical Trial Not Allowed)

Estados Unidos · US

Quién puede pedirla Special district governments · Native American tribal organizations (other than Federally recognized tribal governments) · State governments · Independent school districts · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Private institutions of higher education · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Public and State controlled institutions of higher education · Small businesses · City or township governments · For profit organizations other than small businesses · Native American tribal governments (Federally recognized) · Public housing authorities/Indian housing authorities · County governments

The NIH INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Project seeks to improve health and quality-of-life for individuals with Down syndrome. This Notice of Funding Opportunity (NOFO) invites researchers to submit applications for support of new exploratory and developmental research projects that address critical needs for Down syndrome projects, as articulated in the INCLUDE Project objectives. For example, such projects could assess the feasibility of a novel area of investigation or a new experimental system that has the potential to enhance health-related research. Another example could include the unique and innovative use of an existing methodology to explore a new scientific area. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research.

(DIN) Acciones de Dinamización Comercial (Reg. Mímimis 2023/2831)

AUTONOMICA - LA RIOJA - AGENCIA DE DESARROLLO ECONÓMICO DE LA RIOJA ·

Comercio, Turismo y Pymes

Programa de Subvenciones para Instrumentación Compartida (SIG) (Ensayo Clínico S10 No Permitido)

Estados Unidos · US

Quién puede pedirla Native American tribal organizations (other than Federally recognized tribal governments) · Private institutions of higher education · Independent school districts · City or township governments · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Small businesses · Special district governments · County governments · Others (see text field entitled "Additional Information on Eligibility" for clarification) · For profit organizations other than small businesses · Native American tribal governments (Federally recognized) · State governments · Public and State controlled institutions of higher education · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Public housing authorities/Indian housing authorities

Este Aviso de Oportunidad de Financiamiento (NOFO) anuncia el Programa de Subvenciones para Instrumentación Compartida (SIG) reestructurado que consolida tres programas existentes de instrumentación de uso compartido, es decir, el programa de Subvenciones para Instrumentación Compartida, el programa de Subvenciones para Instrumentación de Alta Gama y el programa de Subvenciones para Instrumentación Básica. El NOFO invita a presentar solicitudes de grupos de investigadores apoyados por los NIH para comprar o actualizar un único instrumento comercialmente disponible de última generación o un sistema de instrumentación integrado. Los instrumentos adquiridos a través del Programa SIG deben compartirse de manera óptima entre los usuarios para garantizar operaciones de investigación eficientes y rentables, permitir mediciones rigurosas y reproducibles, y fomentar la investigación colaborativa y beneficiar a las comunidades de investigación en general. El premio mínimo es de $300,000. No hay límite en el costo total del instrumento; sin embargo, el premio máximo es de $5,000,000. Se requiere la participación en los costos para instrumentos premium o instrumentos de uso especial.

Programa de Apoyo a la Instrumentación de Semillas (SIS) (Ensayo Clínico S10 No Permitido)

Estados Unidos · US

Quién puede pedirla Special district governments · Native American tribal governments (Federally recognized) · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Public housing authorities/Indian housing authorities · Private institutions of higher education · For profit organizations other than small businesses · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Public and State controlled institutions of higher education · Independent school districts · Small businesses · County governments · City or township governments · State governments · Native American tribal organizations (other than Federally recognized tribal governments)

Esta Notificación de Oportunidad de Financiamiento (NOFO) tiene como objetivo construir nueva capacidad de investigación y desarrollar un programa de investigación sostenible apoyando la compra de un único instrumento de investigación biomédica disponible comercialmente que actualmente no está disponible en la institución. Los instrumentos financiados a través de este programa deben ser compartidos entre los usuarios para crear nuevas oportunidades de investigación, permitir la generación de datos reproducibles, fomentar la investigación colaborativa y la capacitación, y fortalecer las capacidades de investigación a largo plazo. El premio mínimo es de $50,000. Si bien no hay límite en el costo total del instrumento, el premio máximo es de $400,000.

Native American Research Centers for Health (NARCH) Planning Grants (R34 - Clinical Trial Not Allowed)

Estados Unidos · US

Quién puede pedirla Native American tribal governments (Federally recognized) · Native American tribal organizations (other than Federally recognized tribal governments)

The purpose of the Native American Research Centers for Health (NARCH) Planning Grants program is to support federally recognized American Indian/Alaska Native (AI/AN) Tribes, Tribal colleges and universities, Tribal health programs, or Tribal organizations (collectively, eligible AI/AN Tribal entities) to plan and conduct preparatory work for developing competitive NARCH applications.

Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)

Estados Unidos · US

Quién puede pedirla Small businesses · Public housing authorities/Indian housing authorities · City or township governments · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Native American tribal organizations (other than Federally recognized tribal governments) · Native American tribal governments (Federally recognized) · State governments · Private institutions of higher education · Special district governments · For profit organizations other than small businesses · Independent school districts · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · County governments · Public and State controlled institutions of higher education · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education

This Notice of Funding Opportunity (NOFO) invites researchers to submit applications for support of clinical projects that address critical needs for clinical trial readiness in rare diseases. The initiative seeks applications that are intended to facilitate rare diseases research by enabling efficient and effective movement of candidate therapeutics or diagnostics toward clinical trials, and to increase their likelihood of success. This could be through the development and testing of rigorous biomarkers and clinical outcome assessment measures, or by defining the presentation and course of a rare disease to enable the design of upcoming clinical trials.

BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development Department of Defense

Estados Unidos · US

Quién puede pedirla Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

The FY23 -FY28 Broad Agency Announcement for Extramural Biomedical Research and Development - HT9425-23-S-SOC1.